Holen Sie sich die Stockscreener-App
3.25
1.88%
0.06
Handel nachbörslich:
3.21
-0.04
-1.23%
Schlusskurs vom Vortag:
$3.19
Offen:
$3.19
24-Stunden-Volumen:
82,807
Relative Volume:
0.36
Marktkapitalisierung:
$77.83M
Einnahmen:
$48.20M
Nettoeinkommen (Verlust:
$-35.05M
KGV:
-2.0736
EPS:
-1.5673
Netto-Cashflow:
$-13.02M
1W Leistung:
-9.47%
1M Leistung:
+65.82%
6M Leistung:
+47.06%
1J Leistung:
+8.70%
1-Tages-Spanne:
$3.15
$3.4999
1-Wochen-Bereich:
$2.95
$3.59
52-Wochen-Spanne:
$1.06
$5.22
Celularity Inc Stock (CELU) Company Profile
Firmenname
Celularity Inc
Sektor
Branche
Telefon
(908) 768-2170
Adresse
170 PARK AVE, FLORHAM PARK
Vergleichen Sie CELU mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CELU
Celularity Inc
|
3.25 | 76.40M | 48.20M | -35.05M | -13.02M | -1.5673 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.16 | 120.29B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
554.58 | 60.26B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
339.80 | 43.10B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
598.89 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.94 | 33.09B | 3.81B | -644.79M | -669.77M | -6.24 |
Celularity Inc Stock (CELU) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-01-30 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-12-22 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-06-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-04-06 | Herabstufung | Truist | Buy → Hold |
| 2022-01-28 | Eingeleitet | Oppenheimer | Outperform |
| 2021-11-24 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Celularity Inc Aktie (CELU) Neueste Nachrichten
Celularity Secures $2M Through Private Placement Deal - TipRanks
Celularity (CELU) raises $2M via private placement, issues warrants | PDS SEC FilingForm 6-K - Stock Titan
Technical Charts Suggest Momentum Shift in Celularity Inc.Market Entry and Exit Point Tips From Traders - metal.it
What makes Celularity Inc. stock price move sharplyWeekly Stock Watch With Growth Focus Expanded - metal.it
Intrinsic Value of Celularity Inc. Stock: Is It Undervalued or OvervaluedTriple Digit Return Stock Predictions Released - metal.it
Options Data Show Bullish Bias in Celularity Inc.Risk Adjusted Technical Entry Plan Gains Followers - metal.it
Why Celularity Inc. Equity Warrant stock attracts strong analyst attentionAI Driven Stock Trend Forecast Shows Momentum Shift - metal.it
Celularity Inc. Equity Warrant At Decision Level — Rebound or ResistanceChart Breakout Buy Signal Detection Confirmed - metal.it
What are the latest earnings results for Celularity Inc.Outstanding yields - jammulinksnews.com
Celularity Inc. Ranks High in Smart Money TrackerSmart Investment Tips Gaining Popularity Among Analysts - metal.it
Should I hold or sell Celularity Inc. Equity Warrant stock in 2025Value Investing Report For 2025 - jammulinksnews.com
Celularity Inc. Equity Warrant Matches Institutional Buying FilterRisk Controlled Short Term Trade Plans Published - metal.it
When is Celularity Inc. stock expected to show significant growthFind market-beating stocks for your portfolio - jammulinksnews.com
Smart tools for monitoring Celularity Inc.’s price actionIntraday Strategy with Real Time Monitoring - Newser
When is Celularity Inc. Equity Warrant stock expected to show significant growthBeginner Investor Planner With Proven Results - jammulinksnews.com
How strong is Celularity Inc. company’s balance sheetStock Market Report For Consistent Profits - jammulinksnews.com
What are analysts’ price targets for Celularity Inc. Equity Warrant in the next 12 monthsFree Stock Market Return Analysis - jammulinksnews.com
Is Celularity Inc. Equity Warrant stock overvalued or undervaluedInvest confidently with daily market forecasts - jammulinksnews.com
What institutional investors are buying Celularity Inc. Equity Warrant stockGrow your portfolio with growth-oriented stocks - jammulinksnews.com
What are the latest earnings results for Celularity Inc. Equity WarrantHigh-yield growth strategies - jammulinksnews.com
What are Celularity Inc. company’s key revenue driversMaximize gains with data-driven trading alerts - jammulinksnews.com
What institutional investors are buying Celularity Inc. stockStay informed with daily expert analysis - jammulinksnews.com
Key External Factors That Drive Celularity Inc. Stock Price MovementsMarket Beating Strategy - metal.it
Celularity Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingFree Stock Selection with 300% Return - Newser
What analysts say about Celularity Inc. stockExponential wealth increase - PrintWeekIndia
What analysts say about Celularity Inc. Equity Warrant stockFree Investment Community - PrintWeekIndia
Is Celularity Inc. stock overhyped or has real potentialFree Investment Community - jammulinksnews.com
What drives Celularity Inc. stock priceMarket-beating performance - PrintWeekIndia
Is Celularity Inc. Equity Warrant a good long term investmentSkyrocketing investment returns - PrintWeekIndia
Celularity Inc. Stock Analysis and ForecastMassive profits - PrintWeekIndia
What drives Celularity Inc. Equity Warrant stock priceUnprecedented market success - PrintWeekIndia
Is Celularity Inc. a good long term investmentExponential wealth increase - Autocar Professional
Celularity Finalizes Private Placement Agreement - TipRanks
Finanzdaten der Celularity Inc-Aktie (CELU)
Umsatz
Nettogewinn
Free Cashflow
ENV
Celularity Inc-Aktie (CELU) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Hariri Robert J | Chief Executive Officer |
Apr 13 '25 |
Option Exercise |
0.00 |
3,281 |
0 |
21,482 |
| Haines John R | Senior Exec Vice President |
Apr 13 '25 |
Option Exercise |
0.00 |
1,641 |
0 |
29,698 |
| Beers David C | Chief Financial Officer |
Apr 13 '25 |
Option Exercise |
0.00 |
1,025 |
0 |
18,561 |
| Brigido Stephen | Pres., Functional Regeneration |
Feb 17 '25 |
Option Exercise |
0.00 |
10,000 |
0 |
11,641 |
| Beers David C | Chief Financial Officer |
Feb 17 '25 |
Option Exercise |
0.00 |
12,500 |
0 |
21,932 |
| Haines John R | Senior Exec Vice President |
Feb 17 '25 |
Option Exercise |
0.00 |
20,000 |
0 |
35,092 |
0.23%
0.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):